JPMorgan lowered the firm’s price target on Bath & Body Works to $41 from $47 and keeps an Overweight rating on the shares. The firm adjusted estimates in department stores and specialty softlines following its retail conference.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Apple, Starbucks upgraded: Wall Street’s top analyst calls
- Bath & Body Works upgraded to Overweight from Neutral at Piper Sandler
- Bath & Body Works price target lowered to $36 from $48 at Citi
- Softlines partially priced in China tariffs, not Vietnam, says Morgan Stanley
- Bath & Body Works files automatic mixed securities shelf